Close mobile menu×
Close mobile menu

Prakash Satwani, MD

Board Certifications: 
Pediatric Hematology-Oncology
Expertise in: 
Cancer Care
Accepting New Patients
Treats Children
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-2466

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Pediatric Hematology-Oncology

Clinical Expertise

  • Cancer Care
  • Pediatric Bone Marrow
  • Thalassemia Failure Syndrome
  • Bone Marrow Stem Cell Transplants
  • Sickle Cell Anemia
  • Neuroblastoma
  • Pediatric Leukemia
  • Pediatric Lymphomas
  • Non-Hodgkin's Lymphoma

Education & Training

  • Grant Medical College of Bombay University (India)
  • Residency: The Brooklyn Hospital
  • Fellowship: Morgan Stanley Children's Hospital of NewYork-Presbyterian

About Prakash Satwani

Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed.

Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment.

Academic Titles

  • Assistant Professor of Pediatrics at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
3959 Broadway
New York, New York 10032
Phone:
(212) 305-9770
Fax:
(212) 305-8408
Primary
2
161 Fort Washington Avenue
New York, New York 10032
Phone:
(212) 305-9770
Fax:
(212) 305-8408

Research

Clinical Trials

NCT02336230 A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD

Grants

A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH CORTICOSTEROIDS VERSUS PLACEBO IN COMBINATION WITH CORTICOSTEROIDS IN SUBJECTS WITH NEW ONSET CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD) (P&S Industry Clinical Trial)

Aug 9 2017 - Aug 9 2022

DSDNA (P&S Industry Clinical Trial)

Jan 10 2011 - Jan 10 2017

COMPARING LONG TERM OUTCOMES IN SURVIVORS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NONMALIGNANT DISEASE BY THE INTENSITY OF PREPARATIVE REGIMEN (Private)

Jul 1 2014 - May 31 2016

RETROSPECTIVE STUDY FOR EBV IN HL (Private)

Dec 17 2014 - Dec 16 2015

REDUCED-INTENSITY CONDITIONING FOR CHILDREN AND ADULTS WITH HEMOPHAGOCYTIC SYNDROMES OR SELECTED PRIMARY IMMUNE DEFICIENCIES (RICHI) - BMT CTN PROTOCOL #1204 (Federal Gov)

Jul 22 2014 - Jul 21 2015

A NOVEL CHEMOTHERAPY (ROMIDEPSIN) AND IMMUNOTHERAPY (NATURAL KILLER CELL)BASED APPROACH IN PEDIATRIC LEUKEMIA AND LYMPHO (Private)

Aug 1 2009 - Jul 31 2010